Hosted on MSN1mon
UCLA-led study reveals PSMA-PET imaging may redefine prostate cancer staging
A new UCLA Health Jonsson Comprehensive Cancer Center-led study has revealed that advanced prostate-specific membrane antigen positron emission tomography (PSMA-PET) imaging could reveal ...
News Medical15d
UCLA Health receives $1.72 million grant to advance brain tumor research and training
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from the National Institutes of Health to support the Neuro-Oncology Translational ...
EurekAlert!15d
UCLA awarded NIH grant to train the next generation of brain cancer scientists
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from the National Institutes of Health to support the Neuro-Oncology Translational ...
U.S. News & World Report19d
Virtual Technology Provides Faster Access to Genetic Testing for Cancer
An online portal streamlines the testing process at UCLA Health. UCLA Health’s virtual genetic counseling tool has markedly increased the percentage of cancer patients undergoing recommended ...
UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects
Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...
Targeted Oncology1d
The Targeted Pulse: The Latest FDA Actions Across Cancer Types and Exploring the Efficiency of Remote Pharmacists in Community Oncology
The FDA makes furthering moves in SCLC, ovarian, and breast cancers, and the value of remote clinical pharmacists is explored in community oncology.